ACT CAPITAL MANAGEMENT, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1442273 WAYNE, PA

Position in ARWR

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$8,974,251

+$3,801,501 QoQ

Shares Held

110,100

+33.5% QoQ

Ownership

0.078%

of shares outstanding

% of Portfolio

5.86%

of 13F equity value

Holder Rank

#102

of 497 holders

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACT CAPITAL MANAGEMENT, LLC holds $97,112,758 across 27 Biotechnology names. ARWR ranks #4 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	45,000	$16,725,150
2	TGTX	Tg Therapeutics, Inc.	251,025	$13,791,313
3	ABVX	Abivax S.A.	97,000	$12,926,220
4	ARWR	Arrowhead Pharmaceuticals, Inc. This page	110,100	$8,974,251
5	VKTX	Viking Therapeutics, Inc.	209,300	$8,164,793
6	CELC	Celcuity Inc.	62,150	$6,502,133
7	NKTR	Nektar Therapeutics	89,300	$6,234,033
8	CYTK	Cytokinetics Inc	47,500	$4,046,525

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,974,251	110,100	+33.5%	Shares	Sole	2026-07-29
2026-03-31	$5,172,750	82,500	+10.0%	Shares	Sole	2026-05-08
2025-12-31	$4,979,250	75,000	-32.1%	Shares	Sole	2026-02-17
2022-09-30	$3,652,025	110,500	-18.1%	Shares	Sole	2022-11-03
2022-06-30	$4,753,350	135,000	-32.8%	Shares	Sole	2022-08-12
2022-03-31	$9,243,990	201,000	-4.5%	Shares	Sole	2022-05-11
2021-12-31	$13,956,150	210,500	+8.5%	Shares	Sole	2022-02-03
2021-09-30	$12,111,420	194,000	-7.0%	Shares	Sole	2021-11-16
2021-06-30	$17,276,252	208,600	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.